首页> 外文期刊>Skin Therapy Letter >Predictive Testing of the Melanocortin 1 Receptor for Skin Cancer and Photoaging
【24h】

Predictive Testing of the Melanocortin 1 Receptor for Skin Cancer and Photoaging

机译:对皮肤癌和光老化的黑皮质素1受体的预测性测试

获取原文
           

摘要

Genetic predisposition to melanoma and nonmelanoma skin cancer extends far beyond the Fitzpatrick phenotype classification scheme. Specific alleles of the gene that codes for the malnocortin 1 receptor are predictive of skin cancer risk independent of skin type and hair color. The ability to identify high risk patients independent of the red hair phenotype may help to modify routine sun and skin monitoring behaviors. In addition, as this increased skin cancer risk is likely due to impaired UVA and UVB defence mechanisms, consideration of genetic predisposition may also be appropriate for patients undergoing psoralen + UVA (PUVA) or UVB treatments for various cutaneous disorders, such as psoriasis, eczema, and vitiligo. Testing aimed at improving prognostication may serve to limit the influence of certain risk factors.
机译:黑色素瘤和非黑色素瘤皮肤癌的遗传易感性远远超出了Fitzpatrick表型分类方案。编码malnocortin 1受体的基因的特定等位基因可预测皮肤癌风险,而与皮肤类型和头发颜色无关。识别与红发表型无关的高危患者的能力可能有助于改变常规的阳光和皮肤监测行为。此外,由于这种增加的皮肤癌风险很可能是由于UVA和UVB防御机制受损而引起的,因此考虑到遗传倾向也可能适用于接受补骨脂素+ UVA(PUVA)或UVB治疗各种皮肤病(如牛皮癣,湿疹)的患者和白癜风。旨在改善预后的测试可能有助于限制某些风险因素的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号